Mammograms Specialist Mustang OK

DCIS is a noninvasive condition in which abnormal cells are found in the lining of a breast duct. It is not cancer, but it may, in some cases, become invasive cancer and spread to other tissues. Because they can’t predict which lesions will become invasive cancer and which will remain contained in the breast duct, doctors usually treat DCIS like cancer.

Midwest Regional Medical Center
(405) 610-4411
2825 Parklawn Drive
Oklahoma City, OK
 
Daniel H Carmichae, MR
(405) 945-4230
PO Box 721143
Oklahoma City, OK
Specialties
Oncology (Cancer)
Gender
Male
Education
Graduation Year: 2007

Data Provided by:
Karl K Boatman, MD
(405) 945-4411
3525 NW 56th St Ste 100C
Oklahoma City, OK
Gender
Male
Education
Medical School: Univ Of Ok Coll Of Med, Oklahoma City Ok 73190
Graduation Year: 1952
Hospital
Hospital: Integris Baptist Med Ctr, Oklahoma City, Ok

Data Provided by:
Jeffrey Joseph Smith, MD
(405) 942-3600
3613 NW 56th St
Oklahoma City, OK
Specialties
Oncology (Cancer), Gynecological Oncology
Gender
Male
Education
Medical School: Mayo Med Sch, Rochester Mn 55905
Graduation Year: 1976

Data Provided by:
M Jafari Boroujerdi, MD
Univ Of Oklahoma Coll Of M
Oklahoma City, OK
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Univ Wurzburg, Med Fak, Wurzburg, Germany (407-20 Pr 1/71)
Graduation Year: 1995

Data Provided by:
Johnny Russell Mc Minn, MD
Yukon, OK
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Univ Of Ok Coll Of Med, Oklahoma City Ok 73190
Graduation Year: 1997

Data Provided by:
Romeo Ang Mandanas, MD
(405) 943-9988
3366 NW Expressway St Ste 200
Oklahoma City, OK
Specialties
Oncology (Cancer), Hematology-Internal Medicine
Gender
Male
Education
Medical School: Cebu Inst Of Med, Cebu City, Philippines
Graduation Year: 1983
Hospital
Hospital: St Anthony Hospital, Oklahoma City, Ok; Integris Baptist Med Ctr, Oklahoma City, Ok; Mercy Health Center, Oklahoma City, Ok
Group Practice: Cancer Care Assoc

Data Provided by:
Tommy L Hewett
(405) 842-2061
3000 United Founders Blvd
Oklahoma City, OK
Specialty
Hematology

Data Provided by:
Dr.Saadia Chohan
(405) 942-9200
Suite D100, 3525 Northwest 56th Street
Oklahoma City, OK
Gender
F
Speciality
Oncologist
General Information
Accepting New Patients: Yes
RateMD Rating
3.5, out of 5 based on 5, reviews.

Data Provided by:
Charles Warren Hollen, MD
(405) 942-9200
3400 NW Expressway St Ste 200
Oklahoma City, OK
Specialties
Oncology (Cancer), Internal Medicine
Gender
Male
Education
Medical School: Univ Of Ok Coll Of Med, Oklahoma City Ok 73190
Graduation Year: 1985
Hospital
Hospital: Integris Baptist Med Ctr, Oklahoma City, Ok
Group Practice: Cancer Care Assoc

Data Provided by:
Data Provided by:

Mandatory Mammograms

Provided by: 

By Vonalda M. Utterback, CN

“Time to make breast pancakes,” says one friend of mine, referring to her scheduled mammography screening. And although she may crack jokes about the experience, she’s never once questioned the need for her annual pilgrimage, nor has her physician discussed the risks versus the benefits it entails. After all, if you are a woman aged 40 or beyond, yearly mammograms are simply de rigueur.

When your doctor refers you for a screening, he or she is likely following the guidelines of the two leading national cancer research and information organizations primarily responsible for setting public health policy on cancer screening: The private American Cancer Society (ACS) and the government’s National Cancer Institute (NCI). Both, along with other well-funded, high-profile organizations, such as Susan G. Komen for the Cure, recommend regular mammogram screening of symptom-free women beginning at age 40.

All this official blessing shouldn’t make regular screening mammography sacrosanct, however. In fact, it’s way past time for women to start asking hard questions about the exam’s efficacy and its potential harm, say many women’s health experts, advocates, and researchers. “Screening mammography is clearly a double-edged sword,” explains Lisa Schwartz, MD, co-director of the Veteran’s Administration Outcomes Group in White River Junction, Vermont, and associate professor of medicine at Dartmouth Medical School.

False truths
According to the National Academy of Sciences 2005 publication, Saving Women’s Lives: Strategies for Improving Breast Cancer Detection and Diagnosis, the risk of a false-positive result in a mammogram is about 1 in 10. About three-quarters of the resulting biopsies turn out to be benign, it’s true, but to learn that a woman has to endure the fear that she has breast cancer and bear the cost, discomfort, and risk of additional medical procedures.

“Regular screening will save some lives, but it will cause even more women to be harmed through the unnecessary diagnosis and treatment of cancer that would never have affected their health, were it not for screening,” says Schwartz. She’s referring to false-positives associated with “ductal carcinoma in situ” (DCIS), a result that many experts consider one of the most harmful risks associated with screening mammography.

DCIS is a noninvasive condition in which abnormal cells are found in the lining of a breast duct. It is not cancer, but it may, in some cases, become invasive cancer and spread to other tissues. Because they can’t predict which lesions will become invasive cancer and which will remain contained in the breast duct, doctors usually treat DCIS like cancer. “Most women with DCIS will be advised to undergo invasive treatment of unknown benefit, such as lumpectomy combined with radiation,” reports Schwartz.
Harm from over-diagnosis of invasive cancer also may occur because many malignant cancers grow quite slowly, says Peter C. Gotzsche, MD, r...

Author: Vonalda M. Utterback, CN

Copyright 1999-2009 Natural Solutions: Vibrant Health, Balanced Living/Alternative Medicine/InnoVisi...